NYSE:ZEPP - Post Discussion
Post by
sdhaka on Sep 04, 2024 7:22pm
Zepp Health’s Q2-2024 results showed a 56% YoY
Hi guys! Zepp Health’s Q2-2024 results showed a 56% YoY revenue drop, primarily due to softer smartwatch demand and stronger competition. While revenue dipped, cost-cutting measures improved gross margins and reduced operating expenses. Global smartwatch shipments are down 9% YoY but are expected to bounce back by 5%-10% in 2024, driven by health trends and AI integration.
Zepp remains the sixth-largest player in the market and is forecasting a strong rebound in H2 with new product launches. With shares trading well below liquid assets, this might be an interesting point to reassess.
Be the first to comment on this post